<DOC>
	<DOCNO>NCT02143999</DOCNO>
	<brief_summary>This observational study evaluate effectiveness BRAF inhibitor current therapy patient newly diagnose metastatic melanoma without BRAF V600 mutation . Patients treat per locally approve therapeutic option clinical practice . The observation period patient 24 month .</brief_summary>
	<brief_title>An Observational Study BRAF Inhibitors Effectiveness Patients With Newly Diagnosed Metastatic Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age diagnosis Histologically confirm new diagnosis unresectable metastatic melanoma Patients tumor sample available assessment BRAF V600 mutation Prior systemic therapy metastatic disease Participation interventional clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>